Trademark: NOZASEPTIN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for NOZASEPTIN
We do not have any records of a proof of use for NOZASEPTIN at this moment.
Possible trademark infringements of NOZASEPTIN
Basic Information about NOZASEPTIN
- Serial Number
- 86057858
- Filing Date
- 06 Sep 2013
- Registration Number
- 4629722
- Registration Date
- 28 Oct 2014
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of NOZASEPTIN on the blockchain with WikiTrademarks.io.
- First use of NOZASEPTIN anywhere
- NOZASEPTIN was first used on 14 Nov 2013 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns NOZASEPTIN?
1. Global Life Technologies Corp. Bethesda MD
2. Global Life Technologies Corp. Chevy Chase MD
3. Global Life Technologies Corp. Chevy Chase MD
Correspondent
- Robert M. Downey Malloy & Malloy, P.L.
- 6751 N FEDERAL HWY STE 300
- BOCA RATON, FL 33487-1647
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io